亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

蘇州麥輪生物科技有限公司  

食品添加劑、膳食補充原料、保健品原料

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:王
  • 電話:0512-66706057-8005
  • 郵件:maggie@mylandpharm.com
  • 微信:18656033903
  • QQ:1677088563
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 亞精胺三***
亞精胺三***
單價 1.00 / 千克對比
銷量 暫無
發貨 江蘇蘇州市付款后3天內
庫存 30千克起訂1千克
過期 長期有效
更新 2022-05-10 15:04
 
詳細信息
產品名稱:亞精胺三***
中文別名:亞精胺三***;三***亞精胺;N-(3-氨丙基)-1,4-丁二胺三***
英文名稱:Spermidine
英文別名:1,4-Butanediamine,N1-(3-aminopropyl)-, hydrochloride (1:3);Spermidine hydrochloride; Spermidinetrihydrochloride; 1,4-Butanediamine,N-(3-aminopropyl)-, trihydrochloride (8CI,9CI); Spermidine trihydrochloride
CAS:334-50-9
分子式:C7H22Cl3N3
分子量:254.63
純度:98%
外觀與性狀:白色粉末
用途:膳食補充原料
©2025 蘇州麥輪生物科技有限公司 版權所有   技術支持:化工網   訪問量:7288  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |